Selvita SA (SLV1)

Currency in PLN
34.40
-0.60(-1.71%)
Closed·
SLV1 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
34.0035.00
52 wk Range
26.5049.40
Key Statistics
Bid/Ask
34.40 / 34.85
Prev. Close
35
Open
35
Day's Range
34-35
52 wk Range
26.5-49.4
Volume
19.71K
Average Volume (3m)
35.78K
1-Year Change
6.5015%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SLV1 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
50.15
Upside
+45.78%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and other. In addition, the company provides drug development services, including formulation development; CMC analytical support; stability and shelf-life determination; clinical supply/GMP manufacturing; small molecules bioanalysis; drug substance and product; and biologics and biosimilars bioanalysis services. Further, it offers research and development services in the areas of agrochemistry analytical support, and flavor and fragrance chemistry. The company was formerly known as Selvita CRO S.A. and changed its name to Selvita S.A. in October 2019. Selvita S.A. was founded in 2007 and is based in Kraków, Poland.

Employees
691
Market
Poland

Compare SLV1 to Peers and Sector

Metrics to compare
SLV1
Peers
Sector
Relationship
P/E Ratio
776.7x−5.7x−0.4x
PEG Ratio
6.93−0.100.00
Price/Book
2.0x2.7x2.6x
Price / LTM Sales
1.7x4.0x3.2x
Upside (Analyst Target)
44.0%57.8%46.2%
Fair Value Upside
Unlock3.7%7.2%Unlock

Analyst Ratings

5 Buy
0 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 50.15
(+45.78% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 26, 2026
EPS / Forecast
0.27 / --
Revenue / Forecast
94.9M / --
EPS Revisions
Last 90 days

SLV1 Income Statement

People Also Watch

187.30
CBF
+0.75%
150.30
DIAP
+1.55%
8.0700
LBW
+0.37%
724.00
NEUP
+4.93%
3,794.00
BFT
-2.42%

FAQ

What Is the Selvita (SLV1) Stock Price Today?

The Selvita stock price today is 34.40 PLN.

What Stock Exchange Does Selvita Trade On?

Selvita is listed and trades on the Warsaw Stock Exchange.

What Is the Stock Symbol for Selvita?

The stock symbol for Selvita is "SLV1."

What Is the Selvita Market Cap?

As of today, Selvita market cap is 631.43M PLN.

What Is Selvita's Earnings Per Share (TTM)?

The Selvita EPS (TTM) is 0.04.

When Is the Next Selvita Earnings Date?

Selvita will release its next earnings report on May 27, 2026.

From a Technical Analysis Perspective, Is SLV1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Selvita Stock Split?

Selvita has split 0 times.

How Many Employees Does Selvita Have?

Selvita has 691 employees.

What is the current trading status of Selvita (SLV1)?

As of Apr 26, 2026, Selvita (SLV1) is trading at a price of 34.40 PLN, with a previous close of 35.00 PLN. The stock has fluctuated within a day range of 34.00 PLN to 35.00 PLN, while its 52-week range spans from 26.50 PLN to 49.40 PLN.

What Is Selvita (SLV1) Price Target According to Analysts?

The average 12-month price target for Selvita is 50.15 PLN, with a high estimate of 65.3 PLN and a low estimate of 40 PLN. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +45.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.